Nordic Pharma SA
1.3 FTENordic Pharma reported total assets of €1.33m at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026), with 1.3 full-time equivalent.
By total assets for 2025, Nordic Pharma ranks among the 500 largest of the 1,495 companies in its sector (NACE 7320) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Nordic Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +66 % Total assets +23 % Headcount (avg FTE) -59 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nordic Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 09 Aug 2022
Nordic Pharma's financial analysis
- Solvency17.5%sector median: 60.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nordic Pharma
Nordic Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0892.926.867
- VAT number
- BE0892926867
- Peppol
- Registered · 0208:0892926867 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Oct 2007
- Registered office
- 2600 Antwerp
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Market research and public opinion polling (NACE 73200)
Nordic Pharma (SA) has been based in Antwerp since 2007, active in: market research and public opinion polling. For 2025, it reports a net profit of 387,245 € and equity of 232,812 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 17.5%, below the median of its sector (60.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Nordic Pharma
Companies in the same business, of comparable size and area, outside its group.
- ENRA Market research and public opinion polling Leuven · balance sheet 928,788 €
- BB Consulting Market research and public opinion polling La Hulpe · balance sheet 889,501 €
- Berry BE Research Market research and public opinion polling Schaerbeek · balance sheet €2.34m
- Innoscience Europe Market research and public opinion polling Leuven · balance sheet 935,994 €
- Savannah Solutions Market research and public opinion polling Woluwe-Saint-Pierre · balance sheet 37,041 €
- Nielsen Media Belgium Market research and public opinion polling Watermael-Boitsfort · balance sheet €1.37m
- Mactan Market research and public opinion polling Lummen · balance sheet €1.06m
- International Basic Industry Group Market research and public opinion polling Halle · balance sheet €1.28m
Frequently asked questions about Nordic Pharma
What is the revenue of Nordic Pharma?
Nordic Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nordic Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0892926867 for Nordic Pharma, if the company is VAT-registered. Its company number (CBE) is 0892.926.867.
Where is the registered office of Nordic Pharma?
According to the CBE register, the registered office of Nordic Pharma is in 2600 Antwerp.
What is the equity of Nordic Pharma?
At the close of the 2025 financial year, the equity of Nordic Pharma amounts to 232,812 €, a solvency of 17.5% of total assets.
How many people work at Nordic Pharma?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Nordic Pharma?
The register lists 7 active mandates at Nordic Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Nordic Pharma within its sector?
By total assets for 2025, Nordic Pharma ranks among the 500 largest of the 1,495 companies in its sector (NACE 7320) in Belgium that filed accounts for that financial year.
The full file of Nordic Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →